Debiopharm centralized API stock, project and experimental data on a Dotmatics research-data platform.
Disconnected data systems and siloed teams made it hard to manage API stock and shipments. Debiopharm partnered with Dotmatics to implement a centralized research-data platform. The page states API, project and experimental data from all sites and CROs become instantly accessible, with prior work searchable and experiments cloneable.
Dotmatics is a scientific informatics software company offering electronic lab notebooks and data platforms for drug discovery and R&D labs.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Dotmatics on its own site — read the original case study on dotmatics.com ↗
Note: Page is thin; details are in a downloadable PDF.
Related use cases
- 01A chemicals and materials company replaced macro-based workflows with Dotmatics Luma to cut analysis turnaround.
- 02A large CRDMO moved chemistry and biology workflows onto the Dotmatics ELN and Data Discovery Platform.
- 03Krystal Biotech rolled the Dotmatics ELN and Platform across five R&D groups.
- 04Sygnature Discovery deployed the Dotmatics ELN and Data Discovery Platform with a client portal.
- 05Charles River rolled out the Dotmatics ELN to about 500 early discovery researchers.
- 06How Bioventus evolved their commercial strategy with real world data and intelligence